New Launched October 2026
Bloom Her Desire
Botanical support for women's desire and intimate well-being.
Spatikama™ is a botanical nutraceutical for women: a combination of licorice and fenugreek extracts. It supports healthy libido and arousal, natural lubrication and intimate comfort, along with mood and hormonal balance.*
Support for desire, comfort and balance.
A woman's desire is shaped by her hormones, her blood flow and her mood, all at once. Spatikama™ combines licorice and fenugreek extracts to support all three.*
- Desire and arousalSupports healthy libido and sexual arousal.*
- Blood flow and lubricationSupports healthy genital blood flow and natural lubrication.*
- Intimate comfortSupports intimate comfort and sexual well-being.*
- Mood and calmSupports mood, focus and a calmer response to everyday stress.*
- Hormonal balanceSupports healthy hormonal balance.*
Made foradult women whose desire has dipped with everyday stress, fatigue or the changes that come with age.
Desire is part of her well-being.
Yet it is rarely talked about, and too often put down to stress or simply getting older. Spatikama™ was made for that conversation.
Source · National Health and Social Life Survey (NHSLS)
Crystal and desire.
Together, feminine balance. Spatikama™: the essence of feminine wellness.
A combination of licorice and fenugreek extracts.
Each extract brings its own mechanism. Together they deliver a single mechanism of action, the dopamine–estrogen pathway, supporting the signals behind desire.*
- 01Licorice
Glycyrrhiza glabra Estrogen and dopamine signaling. Supports the hormone and brain signals that shape desire, and nervous system health.*
- 02Fenugreek
Trigonella foenum-graecum Blood flow. Supports nitric oxide for healthy blood flow, and healthy testosterone levels.*
Ginger (
The dopamine–estrogen mediated pathway.
Spatikama™ modulates estrogen and dopamine signaling. Follow the signal step by step, or tap any part of the pathway to look closer.Scroll to follow the signal through the cell, step by step.
Spatikama™
Activates estrogen-responsive and dopamine-associated molecular pathways, without upregulating ESR1.
ESR1 (ER-α)
Not upregulated by Spatikama™
ERα signaling protective
- Protects dopamine neurons in the striatum
- Regulates D1 and D2 receptor density and sensitivity
ERβ signaling proposed · Glycyrrhiza glabra
- Maintains dopamine transporter (DAT) binding
- Linked to the dopamine synthesis pathway
GPER1 signaling proposed
- Rapid, non-genomic signaling
- Works with membrane-associated ERα/ERβ
Increased tyrosine hydroxylase (TH) expression
62.5 and 31.25 µg/mL
Increased DRD2 expression
62.5 and 31.25 µg/mL
Dopaminergic signaling
- Higher threshold for sexual arousal
- Neuroendocrine regulation
- Anticipatory drive (libido)
- Reward response
↑ PS2 (TFF1) expression
62.5 and 31.25 µg/mL
Strong estrogen-responsive activity
↑ Nitric oxide synthase (NOS)
Estrogen upregulation
↑ Nitric oxide (NO)
Enhanced dopamine release
Drives sexual motivation
From one estrogen signal to dopamine.
Press play to follow the signal through the cell, or tap any part of the pathway. Pink markers show findings demonstrated in vitro; dashed outlines show proposed mechanisms.
It starts with estrogen signaling.
Spatikama™ activates estrogen-responsive and dopamine-associated molecular pathways. In vitro, it did so without upregulating ESR1, the gene for estrogen receptor alpha (ER-α).
Three receptors carry the signal into the cell.
Estrogen acts through ERα (classical genomic signaling), ERβ (classical and non-genomic signaling) and GPER1, a G-protein coupled receptor. ERα signaling protects dopamine neurons; the ERβ route, linked to licorice (
More of the machinery for dopamine.
Tyrosine hydroxylase (TH) turns tyrosine into L-DOPA on the way to dopamine, which acts on D2 receptors and shapes drive, reward and neuroendocrine regulation. In vitro, Spatikama™ increased TH and DRD2 gene expression at 62.5 and 31.25 µg/mL.
A strong estrogen-responsive signal.
PS2 (TFF1) is a marker of estrogen-responsive activity. In vitro, Spatikama™ raised PS2 (TFF1) expression 3-fold at 62.5 and 31.25 µg/mL, without an increase in ESR1.
The estrogen, nitric oxide and dopamine axis.
Estrogen upregulates nitric oxide synthase (NOS). More nitric oxide can enhance dopamine release, which drives sexual motivation. Fenugreek is known to increase nitric oxide production and may contribute to this pathway.
What the pathway supports.
Together, these signals support neuronal protection and plasticity, learning and memory, the reward response, sexual motivation and libido, and overall neuroendocrine balance.*
Studied in women.
Spatikama™ has been through two human clinical studies, an in-vivo efficacy and safety study, and in-vitro work on how it acts.
Across the two human studies, women reported
- Improved vaginal lubrication and less discomfort*
- Calmer emotional responses to stress and less anxiousness*
- A better overall sense of well-being and comfort*
- Greater intimate comfort and sexual well-being*
The details are in the product information
- The full mechanism studyEvery marker and concentration
- Efficacy and safetyIn vivo
- Two human clinical studiesIn women
- Established safetyAcute oral toxicity · OECD 423
- Vertically integratedFrom the field to the finished extract
- Full specificationMarkers, particle size and stability
Ready for the format your brand needs.
Spatikama™ is a light brown, free-flowing, water-soluble powder. It can go into capsules, drinks, shots and powder premixes.
Possible formats
- Capsules400 mg and 600 mg
- Ready to drink5 g
- ShotsSingle-serve drinks
- Powder premixTo mix into drinks
- Actives
- Licorice (
Glycyrrhiza glabra ) and fenugreek (Trigonella foenum-graecum ) extracts - Diluent
- Ginger (
Zingiber officinale ), added only as a diluent - Extraction
- Hydroalcoholic
- Appearance
- Light brown, free-flowing powder
- Solubility in water
- Not less than 75% w/w
- Full specification
- Markers, particle size and stability, in the product information
Be among the first to formulate with it.
- Request a sample
- Product information
- Study summaries
- Private-label support
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Spatikama™ is a Greenspace Herbs ingredient; it is not energized and not part of the Quantum Ayurveda™ range. Claims and regulatory suitability should be reviewed for each target market and finished-product application.